Renata Belfort De Aguiar, MD, PhD
Associate Professor of Medicine (Endocrinology)
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Renata Belfort De Aguiar, MD, PhD, treats diabetes and transplant patients and has a special focus on the relationship between obesity and diabetes.
“Obesity is one of the leading preventable causes of death in the United States and one of the major risk factors for type 2 diabetes,” says Dr. Belfort De Aguiar, who is an assistant professor of medicine (endocrinology) at Yale School of Medicine. She points out that the reasons why people eat poorly is still largely misunderstood. “My research looks into the influence of changes in circulating blood glucose on the activation of brain regions associated with the desire for and intake of high-calorie foods in obese patients with type 2 diabetes.”
Research is driving treatment, and Dr. Belfort De Aguiar likes to reassure patients by telling them about the ever-expanding array of clinical and technical support for diabetes, including new medications and devices.
Education & Training
- ResidencyBoston University (2008)
- PhDFederal University of Rio De Janeiro (2004)
- MSFederal University of Rio De Janeiro (2000)
- MDFederal University of Rio De Janeiro (1993)
Activities
- Blood Glucose Levels Influence Brain Response to Food PicturesSalt Lake City, UT, United States 2017Blood Glucose Levels Influence Brain Response to Food Pictures
- Brain Responses to Postprandial Glucose Levels Influence Weight LossSan Diego, CA, United States 2017Brain Responses to Postprandial Glucose Levels Influence Weight Loss
- Brain Norepinephrine Transporter Participates in the Defense against Hypoglycemia in HumansBoston, MA, United States 2015Brain Norepinephrine Transporter Participates in the Defense against Hypoglycemia in Humans
- Brain Norepinephrine Transporter Participates in the Defense against Hypoglycemia in HumansBoston, MA, United States 2015Brain Norepinephrine Transporter Participates in the Defense against Hypoglycemia in Humans
- Effect of Small Increments in Blood Glucose Levels on Brain Activation and Eating BehaviorChicago, IL, United States 2013Effect of Small Increments in Blood Glucose Levels on Brain Activation and Eating Behavior
- Effect of Mild Hypoglycemia on Regional Brain Activation to Food CuesAtlanta, GA, United States 2009Effect of Mild Hypoglycemia on Regional Brain Activation to Food Cues
- Pioglitazone (PIO) Improves Metabolic and Histologic Parameters in Patients with Non-Alcoholic Steatohepatitis (NASH)San Diego, CA, United States 2005Pioglitazone (PIO) Improves Metabolic and Histologic Parameters in Patients with Non-Alcoholic Steatohepatitis (NASH)
- Effect of a Chronic Elevation in Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Non-Diabetic Offspring with a Family History of T2DMSan Diego, CA, United States 2003Effect of a Chronic Elevation in Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Non-Diabetic Offspring with a Family History of T2DM
- Dose-Response Effects of Acute Elevation in Plasma Free Fatty Acids on Insulin Sensitivity in Type 2 DiabetesRio de Janeiro, RJ, Brazil 2001Dose-Response Effects of Acute Elevation in Plasma Free Fatty Acids on Insulin Sensitivity in Type 2 Diabetes
- Physiological Basis of Thyroid and Assessment of Thyroid FunctionRio de Janeiro, RJ, Brazil 1999Physiological Basis of Thyroid and Assessment of Thyroid Function
- Physiological Basis of Thyroid and Assessment of Thyroid FunctionRio de Janeiro, RJ, Brazil 1999Physiological Basis of Thyroid and Assessment of Thyroid Function
- Physiological Basis of Thyroid and Assessment of Thyroid FunctionRio de Janeiro, RJ, Brazil 1998Physiological Basis of Thyroid and Assessment of Thyroid Function
- Physiological Basis of Thyroid and Assessment of Thyroid FunctionRio de Janeiro, RJ, Brazil 1998Physiological Basis of Thyroid and Assessment of Thyroid Function
- Treatment of Gestational Diabetes and Diabetes & Pregnancy, Lipodystrophy, Ethiopathogeny of Diabetes, Oral Hypoglycemia on DMNID, DM and HyperlipidemiaRio de Janeiro, RJ, Brazil 1996Treatment of Gestational Diabetes and Diabetes & Pregnancy, Lipodystrophy, Ethiopathogeny of Diabetes, Oral Hypoglycemia on DMNID, DM and Hyperlipidemia
- Treatment of Gestational Diabetes and Diabetes & Pregnancy, Lipodystrophy, Ethiopathogeny of Diabetes, Oral Hypoglycemia on DMNID, DM and HyperlipidemiaRio de Janeiro, RJ, Brazil 1996Treatment of Gestational Diabetes and Diabetes & Pregnancy, Lipodystrophy, Ethiopathogeny of Diabetes, Oral Hypoglycemia on DMNID, DM and Hyperlipidemia
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Mentor-Based Minority Postdoctoral Fellowship Program | American Diabetes Assoc. / Takeda Pharmaceuticals | 2007 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Section of Endocrinology Gender Equity Task Force | Committee Member | 2018 - Present |
| Committee on the Status of Women in Medicine (SWIM) Department Liaison | Internal Medicine Intern Selection Committee | 2018 - Present |
| International Journal of Obesity | Reviewer | 2018 - Present |
| YNHHS Formulary Integration Committee’s (FIC) Endocrine Subcommittee | Committee Member | 2017 - Present |
| Diabetes, Obesity and Metabolism | Reviewer | 2017 - Present |
| Internal Medicine Intern Selection Committee | Committee Member | 2016 - Present |
| Archives of Endocrinology and Metabolism | Reviewer | 2015 - Present |
| Endocrinology, Diabetes and Metabolism Case Reports | Senior Editor | 2013 - 2017 |
| Journal of Clinical Endocrinology and Metabolism | Reviewer | 2013 - Present |